Baker Bros. Advisors’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $82.2K | Hold |
|
|||||
|
2022
Q4 | $179K | Hold |
|
|||||
|
2022
Q3 | $299K | Hold |
|
|||||
|
2022
Q2 | $296K | Hold |
|
|||||
|
2022
Q1 | $538K | Hold |
|
|||||
|
2021
Q4 | $371K | Hold |
|
|||||
|
2021
Q3 | $727K | Hold |
|
|||||
|
2021
Q2 | $822K | Hold |
|
|||||
|
2021
Q1 | $937K | Hold |
|
|||||
|
2020
Q4 | $879K | Hold |
|
|||||
|
2020
Q3 | $1.64M | Hold |
|
|||||
|
2020
Q2 | $1.85M | Hold |
|
|||||
|
2020
Q1 | $1.17M | Sell |
|
|||||
|
2019
Q4 | $3.45M | Hold |
|
|||||
|
2019
Q3 | $2.81M | Hold |
|
|||||
|
2019
Q2 | $4.55M | Hold |
|
|||||
|
2019
Q1 | $9.02M | Hold |
|
|||||
|
2018
Q4 | $7.82M | Hold |
|
|||||
|
2018
Q3 | $16.5M | Sell |
|
|||||
|
2018
Q2 | $30.2M | Sell |
|
|||||
|
2018
Q1 | $27.2M | Sell |
|
|||||
|
2017
Q4 | $42.3M | Hold |
|
|||||
|
2017
Q3 | $58.1M | Hold |
|
|||||
|
2017
Q2 | $58.8M | Hold |
|
|||||
|
2017
Q1 | $62.1M | Buy |
|
|||||
|
2016
Q4 | $66.3M | Hold |
|
|||||
|
2016
Q3 | $96.8M | Hold |
|
|||||
|
2016
Q2 | $63.1M | Hold |
|
|||||
|
2016
Q1 | $45.5M | Hold |
|
|||||
|
2015
Q4 | $98.6M | Buy |
|
|||||
|
2015
Q3 | $60.9M | Hold |
|
|||||
|
2015
Q2 | $89.1M | Hold |
|
|||||
|
2015
Q1 | $97.1M | Sell |
|
|||||
|
2014
Q4 | $98.7M | Buy |
|